197 related articles for article (PubMed ID: 32728004)
1. Steroid-Refractory Protein-Losing Enteropathy with Gastrointestinal Bleeding in a Patient with Fontan Circulation.
Iwamoto Y; Matsumura S; Ishido H; Senzaki H; Masutani S
Int Heart J; 2020; 61(4):851-855. PubMed ID: 32728004
[TBL] [Abstract][Full Text] [Related]
2. An Early Glenn Operation May be Associated with the Later Occurrence of Protein-Losing Enteropathy in Fontan Patients : Association of Early Glenn and Failing Fontan.
Unseld B; Stiller B; Borth-Bruhns T; du Bois F; Kroll J; Grohmann J; Fleck T
Pediatr Cardiol; 2017 Aug; 38(6):1155-1161. PubMed ID: 28534240
[TBL] [Abstract][Full Text] [Related]
3. Resolution of protein-losing enteropathy and normalization of mesenteric Doppler flow with sildenafil after Fontan.
Uzun O; Wong JK; Bhole V; Stumper O
Ann Thorac Surg; 2006 Dec; 82(6):e39-40. PubMed ID: 17126088
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal bleeding and protein-losing enteropathy after the fontan operation.
Vyas H; Driscoll DJ; Cetta F; Loftus CG; Connolly HM
Am J Cardiol; 2006 Sep; 98(5):666-7. PubMed ID: 16923458
[TBL] [Abstract][Full Text] [Related]
5. Protein-losing enteropathy after Fontan operation: resolution after baffle fenestration.
Jacobs ML; Rychik J; Byrum CJ; Norwood WI
Ann Thorac Surg; 1996 Jan; 61(1):206-8. PubMed ID: 8561554
[TBL] [Abstract][Full Text] [Related]
6. Protein-losing enteropathy following the Fontan operation.
Rao PS
J Invasive Cardiol; 2007 Oct; 19(10):447-8. PubMed ID: 17906349
[No Abstract] [Full Text] [Related]
7. Successful use of long-acting octreotide for protracted gastrointestinal bleeding related to protein-losing enteropathy after the Fontan procedure: a case report.
Kogawa K; Ando T; Fujiwara M
Cardiol Young; 2021 Aug; 31(8):1333-1335. PubMed ID: 33588957
[TBL] [Abstract][Full Text] [Related]
8. Transcatheter fenestration of autologous pericardial extracardiac Fontan via the transhepatic approach.
Recto MR; Sobczyk WL; Austin EH
J Invasive Cardiol; 2005 Nov; 17(11):628-30. PubMed ID: 16264217
[TBL] [Abstract][Full Text] [Related]
9. Successful diuretics treatment of protein-losing enteropathy in Noonan syndrome.
Mizuochi T; Suda K; Seki Y; Yanagi T; Yoshimoto H; Kudo Y; Iemura M; Tanikawa K; Matsuishi T
Pediatr Int; 2015 Apr; 57(2):e39-41. PubMed ID: 25868959
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Subclinical Enteric Alpha-1-Antitrypsin Loss in Children with Univentricular Circulation Following Total Cavopulmonary Connection.
Breatnach CR; Cleary A; Prendiville T; Crumlish K; Murchan H; McMahon CJ
Pediatr Cardiol; 2018 Jan; 39(1):33-37. PubMed ID: 28879464
[TBL] [Abstract][Full Text] [Related]
11. Recurrent protein-losing enteropathy and tricuspid valve insufficiency in a transplanted heart: a causal relationship?
Aggarwal S; Delius RE; Walters HL; L'Ecuyer TJ
Congenit Heart Dis; 2012; 7(3):E10-3. PubMed ID: 21801319
[TBL] [Abstract][Full Text] [Related]
12. Strategies to treat protein-losing enteropathy.
Rychik J; Spray TL
Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu; 2002; 5():3-11. PubMed ID: 11994860
[TBL] [Abstract][Full Text] [Related]
13. Protein-losing enteropathy after the modified fontan operation: oral prednisone treatment with biopsy and laboratory proved improvement.
Zellers TM; Brown K
Pediatr Cardiol; 1996; 17(2):115-7. PubMed ID: 8833498
[TBL] [Abstract][Full Text] [Related]
14. Thoracic Duct Decompression for Protein-Losing Enteropathy in Failing Fontan Circulation.
António M; Gordo A; Pereira C; Pinto F; Fragata I; Fragata J
Ann Thorac Surg; 2016 Jun; 101(6):2370-3. PubMed ID: 27211948
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Clinical Profiles in Patients with Protein-Losing Enteropathy With and Without Fontan Circulation.
Ono S; Ohuchi H; Miyazaki A; Yamada O
Pediatr Cardiol; 2018 Oct; 39(7):1290-1298. PubMed ID: 29789917
[TBL] [Abstract][Full Text] [Related]
16. Venous Properties in a Fontan Patient with Successful Remission of Protein-Losing Enteropathy.
Kuwata S; Saiki H; Takanashi M; Fukunishi T; Miyaji K; Senzaki H
Int Heart J; 2021; 62(3):710-714. PubMed ID: 34054004
[TBL] [Abstract][Full Text] [Related]
17. Fontan-associated protein-losing enteropathy and post‒heart transplant outcomes: A multicenter study.
Schumacher KR; Yu S; Butts R; Castleberry C; Chen S; Edens E; Godown J; Johnson J; Kemna M; Lin K; Lowery R; Simpson K; West S; Wilmot I; Gossett JG
J Heart Lung Transplant; 2019 Jan; 38(1):17-25. PubMed ID: 30391195
[TBL] [Abstract][Full Text] [Related]
18. Reversal of protein losing enteropathy with prednisone in adults with modified fontan operations: long term palliation or bridge to cardiac transplantation?
Therrien J; Webb GD; Gatzoulis MA
Heart; 1999 Aug; 82(2):241-3. PubMed ID: 10409545
[TBL] [Abstract][Full Text] [Related]
19. Fontan-associated protein-losing enteropathy and heart transplant: A Pediatric Heart Transplant Study analysis.
Schumacher KR; Gossett J; Guleserian K; Naftel DC; Pruitt E; Dodd D; Carboni M; Lamour J; Pophal S; Zamberlan M; Gajarski RJ
J Heart Lung Transplant; 2015 Sep; 34(9):1169-76. PubMed ID: 25987313
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of High-dose Spironolactone Therapy in a Patient with Recurrent Protein-losing Enteropathy after the Fontan Procedure.
Okano S; Sugimoto M; Takase M; Iseki K; Kajihama A; Azuma H
Intern Med; 2016; 55(12):1611-4. PubMed ID: 27301514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
